• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Singapore·Financial Services·NOAH
Held by 1 Guru
Share

Noah Holdings Limited Stocks

$ 6.38Last Updated 16.11.2026

Issuer Rating

4/7
Performance

Favourable

Risk

High

Recommendation

Hold

Market Cap

$ 435.20M

$ 6.38
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Excellent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
Kenneth GriffinCITADEL ADVISORS LLC0.0%+0.00%

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Noah Holdings Limited, together with its subsidiaries, operates as a wealth and asset management service provider with the focus on investment and asset allocation services for high net worth individuals and corporate entities in Mainland of China, Hong Kong, and internationally. It operates through Domestic Public Securities, Domestic Asset Management, Domestic Insurance, Overseas Wealth Management, Overseas Asset Management, and Overseas Insurance and Comprehensive Services segments. The company offers mutual fund products, which are publicly-raised, public securities investment funds, including money market funds; private secondary products; private equity products; investor education; trust services; and insurance products by referring clients, as well as individual whole life insurance, participating insurance, and individual health insurance products. It also provides domestic and overseas private equity, FOFs, public securities, real estate, and multi-strategy and other investments, as well as manages feeder funds. Noah Holdings Limited was founded in 2005 and is headquartered in Singapore.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is overpriced on P/E.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Very favourable
7/7

The average target price of NOAH is 9.86 and suggests 54.9% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

17.11.2026 20:55

A Restaurant Owner Without a Contract with Guests: An Investor Says Anthropic’s Main Risk Isn’t a Loss

17.11.2026 19:28

"The Neoclouds Are in Big Trouble": Steve Eisman Names the Main Victims of the Nvidia Scandal

17.11.2026 19:28

Anthropic to Price IPO Shares at the Top of the Range — Bloomberg

17.11.2026 19:10

Anthropic received a "buy" recommendation ahead of its IPO. What convinced the analyst?

17.11.2026 18:44

Shares of a biotech company backed by AstraZeneca plummeted following the FDA's rejection. Should you sell?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026